Cargando…
Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598898/ https://www.ncbi.nlm.nih.gov/pubmed/33163976 http://dx.doi.org/10.1016/S2665-9913(20)30382-9 |
| _version_ | 1783602744068669440 |
|---|---|
| author | Schreiber, Karen Sciascia, Savino Bruce, Ian N Giles, Ian Cuadrado, Maria J Cohen, Hannah Gordon, Caroline Isenberg, David Jacobsen, Søren Middeldorp, Saskia Mosca, Marta Pavord, Sue Radin, Massimo Roccatello, Dario Salmon, Jane Vinet, Evélyne Voss, Anne Watkins, Linda Hunt, Beverley J |
| author_facet | Schreiber, Karen Sciascia, Savino Bruce, Ian N Giles, Ian Cuadrado, Maria J Cohen, Hannah Gordon, Caroline Isenberg, David Jacobsen, Søren Middeldorp, Saskia Mosca, Marta Pavord, Sue Radin, Massimo Roccatello, Dario Salmon, Jane Vinet, Evélyne Voss, Anne Watkins, Linda Hunt, Beverley J |
| author_sort | Schreiber, Karen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7598898 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75988982020-11-02 Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians Schreiber, Karen Sciascia, Savino Bruce, Ian N Giles, Ian Cuadrado, Maria J Cohen, Hannah Gordon, Caroline Isenberg, David Jacobsen, Søren Middeldorp, Saskia Mosca, Marta Pavord, Sue Radin, Massimo Roccatello, Dario Salmon, Jane Vinet, Evélyne Voss, Anne Watkins, Linda Hunt, Beverley J Lancet Rheumatol Correspondence Elsevier Ltd. 2020-12 2020-10-29 /pmc/articles/PMC7598898/ /pubmed/33163976 http://dx.doi.org/10.1016/S2665-9913(20)30382-9 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Schreiber, Karen Sciascia, Savino Bruce, Ian N Giles, Ian Cuadrado, Maria J Cohen, Hannah Gordon, Caroline Isenberg, David Jacobsen, Søren Middeldorp, Saskia Mosca, Marta Pavord, Sue Radin, Massimo Roccatello, Dario Salmon, Jane Vinet, Evélyne Voss, Anne Watkins, Linda Hunt, Beverley J Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians |
| title | Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians |
| title_full | Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians |
| title_fullStr | Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians |
| title_full_unstemmed | Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians |
| title_short | Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians |
| title_sort | hydroxychloroquine in patients with rheumatic diseases during the covid-19 pandemic: a letter to clinicians |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598898/ https://www.ncbi.nlm.nih.gov/pubmed/33163976 http://dx.doi.org/10.1016/S2665-9913(20)30382-9 |
| work_keys_str_mv | AT schreiberkaren hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT sciasciasavino hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT bruceiann hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT gilesian hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT cuadradomariaj hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT cohenhannah hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT gordoncaroline hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT isenbergdavid hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT jacobsensøren hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT middeldorpsaskia hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT moscamarta hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT pavordsue hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT radinmassimo hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT roccatellodario hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT salmonjane hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT vinetevelyne hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT vossanne hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT watkinslinda hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians AT huntbeverleyj hydroxychloroquineinpatientswithrheumaticdiseasesduringthecovid19pandemicalettertoclinicians |